Bayer AG (BAYRY)
7.61
+0.01
(+0.13%)
USD |
OTCM |
May 06, 16:00
Bayer Cash from Investing (TTM): -3.808B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -3.808B |
September 30, 2023 | 354.65M |
June 30, 2023 | 200.91M |
March 31, 2023 | -1.623B |
December 31, 2022 | -2.511B |
September 30, 2022 | -3.627B |
June 30, 2022 | -6.443B |
March 31, 2022 | -2.910B |
December 31, 2021 | 1.012B |
September 30, 2021 | 2.058B |
June 30, 2021 | 1.764B |
March 31, 2021 | 762.24M |
December 31, 2020 | -4.651B |
September 30, 2020 | -4.502B |
June 30, 2020 | -1.349B |
March 31, 2020 | -1.499B |
December 31, 2019 | -751.18M |
September 30, 2019 | -2.065B |
June 30, 2019 | 6.889B |
March 31, 2019 | -37.71B |
December 31, 2018 | -40.33B |
September 30, 2018 | -37.02B |
June 30, 2018 | -45.68B |
March 31, 2018 | -1.807B |
December 31, 2017 | -489.24M |
Date | Value |
---|---|
September 30, 2017 | -7.997B |
June 30, 2017 | -10.28B |
March 31, 2017 | -10.36B |
December 31, 2016 | -9.661B |
September 30, 2016 | -4.926B |
June 30, 2016 | -3.753B |
March 31, 2016 | -2.903B |
December 31, 2015 | -3.065B |
September 30, 2015 | -14.14B |
June 30, 2015 | -18.21B |
March 31, 2015 | -18.35B |
December 31, 2014 | -20.66B |
September 30, 2014 | -9.625B |
June 30, 2014 | -5.189B |
March 31, 2014 | -5.917B |
December 31, 2013 | -3.428B |
September 30, 2013 | -3.296B |
June 30, 2013 | -4.848B |
March 31, 2013 | -373.37M |
December 31, 2012 | -1.047B |
September 30, 2012 | -1.327B |
June 30, 2012 | -1.342B |
March 31, 2012 | -5.808B |
December 31, 2011 | -5.424B |
September 30, 2011 | -5.910B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-6.443B
Minimum
Jun 2022
6.889B
Maximum
Jun 2019
-1.195B
Average
-1.499B
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
Affimed NV | -39.04M |
InflaRx NV | -19.16M |
MorphoSys AG | -- |
BioNTech SE | -7.529B |
Immatics NV | -33.98M |